Revenue

Brains On-Line is a preclinical CRO. (Image: iStock/ktsimage)

Charles River acquisition builds CNS expertise

By Melissa Fassbender

Charles River Laboratories has acquired Brains On-Line in an ongoing effort to deepen its drug discovery capabilities and build out its portfolio through strategic acquisitions.

There’s no indication that outsourcing will see any slowdown. (Image: iStock/shuvro ghose)

CRO earnings report roundup

By Melissa Fassbender

Over the past several weeks, the CRO industry has released its financial results – and there is no indication of slowdown, says analyst. 

iStock\Gajus

Cambrex predicts flat generic API sales for 2016

Cambrex to start work on Pharma 4 API site in 2016

By Gareth Macdonald

Cambrex has said it will invest around $20m in its Pharma 4 API facility before the end of the year in an effort to get ahead of the capacity utilisation curve.

iStock/theojohns

Patheon will list on NYSE today

By Gareth Macdonald

API and drug maker Patheon will begin trading on the New York Stock Exchange under the symbol PTHN later today.

The complexity of clinical trials makes converting new business into revenue challenging. (Image: iStock/AndreyPopov)

Parexel CFO talks earnings, new business

By Melissa Fassbender

Parexel has announced its financial results for the third quarter of FY16, which remained strong in spite of the complexities associated with smaller clinical trials.

(Image: iStock)

Quintiles, IMS Health merge

By Melissa Fassbender

Quintiles and IMS Health have merged to form Quintiles IMS Holdings, effectively creating one of the world’s largest healthcare information portfolios.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers